South Carolina Code of Laws
Chapter 53 - Poisons, Drugs And Other Controlled Substances
Section 44-53-1645. Requirement to review patient's prescription history.

(A) A practitioner, or the practitioner's authorized delegate, shall review a patient's controlled substance prescription history and history of the administering of an opioid antidote to the patient pursuant to Section 44-130-60 or 44-130-80, as maintained in the prescription monitoring program, before the practitioner issues a prescription for a Schedule II controlled substance. If an authorized delegate reviews a patient's controlled substance prescription history and history of the administering of an opioid antidote to the patient as provided in this subsection, the practitioner must consult with the authorized delegate regarding the prescription and opioid antidote administering history before issuing a prescription for a Schedule II controlled substance. The consultation must be documented in the patient's medical record.
(B) The requirements of this section do not apply to:
(1) a practitioner issuing a prescription for a Schedule II controlled substance to treat a hospice-certified patient;
(2) a practitioner issuing a prescription for a Schedule II controlled substance that does not exceed a five-day supply for a patient;
(3) a practitioner prescribing a Schedule II controlled substance for a patient with whom the practitioner has an established relationship for the treatment of a chronic condition; however, the practitioner must review the patient's controlled substance history maintained in the prescription monitoring program at least every three months;
(4) a practitioner approving the administration of a Schedule II controlled substance by a health care provider licensed in South Carolina;
(5) a practitioner prescribing a Schedule II controlled substance for a patient in a skilled nursing facility, nursing home, community residential care facility, or an assisted living facility and the patient's medications are stored, given, and monitored by staff; or
(6) a practitioner who is temporarily unable to access the prescription monitoring program due to exigent circumstances; however, the exigent circumstances and the potential adverse impact to the patient if the prescription is not issued timely must be documented in the patient's medical record.
(C) A practitioner is deemed to be in compliance with this section if the practitioner utilizes technology that automatically displays the patient's controlled substance prescription history from the prescription monitoring program in the practitioner's electronic medical record system. The practitioner must be able to demonstrate that this technology has been deployed in his practice, but no additional documentation is required in the patient's medical record.
HISTORY: 2017 Act No. 91 (H.3824), Section 1, eff May 19, 2017; 2019 Act No. 65 (H.3728), Section 4, eff January 1, 2021.

Editor's Note
2019 Act No. 65, preamble, provides as follows:
"Whereas, the South Carolina General Assembly is committed to combatting the opioid epidemic occurring within this State; and
"Whereas, the South Carolina General Assembly has enacted and is working to enact legislation aimed at stemming the misuse of opioids in South Carolina; and
"Whereas, collecting information related to opioid use and misuse helps those working to better understand the complexities of substance abuse disorders and enables those working with patients suffering from this disease to develop strategies for treatment, education, and care; and
"Whereas, the purpose of this legislation is to provide data to health care professionals treating patients who have been diagnosed with an opioid overdose and received an antidote in response to that overdose; and
"Whereas, the South Carolina General Assembly intends for the information collected pursuant to this law to be used by health care professionals to assist patients in getting appropriate treatment including, but not limited to, treatment for substance abuse disorder; and
"Whereas, the General Assembly intends further that the information collected pursuant to this law should not be used as the sole determining factor in a decision regarding whether to treat or refuse to treat a patient suffering from an opioid misuse. Now, therefore, [text of act]."
Effect of Amendment
2019 Act No. 65, Section 4, in (A), in the first sentence, inserted "and history of the administering of an opioid antidote to the patient pursuant to Section 44-130-60 or 44-130-80", and in the second sentence, inserted "and history of the administering of an opioid antidote to the patient as provided in this subsection" and "and opioid antidote administering".

Structure South Carolina Code of Laws

South Carolina Code of Laws

Title 44 - Health

Chapter 53 - Poisons, Drugs And Other Controlled Substances

Section 44-53-10. General powers of Department of Health and Environmental Control regarding controlled substances.

Section 44-53-20. "Food" and "drug" defined.

Section 44-53-30. Persons selling certain articles to furnish samples for analysis.

Section 44-53-40. Obtaining certain drugs, devices, preparations, or compounds by fraud or deceit.

Section 44-53-50. Sale of household and commercial laundry detergent and dishwashing detergent containing phosphorus prohibited.

Section 44-53-110. Definitions.

Section 44-53-120. Duties of State Law Enforcement Division.

Section 44-53-130. Coordination of law enforcement.

Section 44-53-140. Certain communications and observations privileged.

Section 44-53-160. Manner in which changes in schedule of controlled substances made.

Section 44-53-170. Nomenclature of controlled substances in schedules.

Section 44-53-180. Tests for inclusion of substance in Schedule I.

Section 44-53-190. Schedule I.

Section 44-53-200. Tests for inclusion of substance in Schedule II.

Section 44-53-210. Schedule II.

Section 44-53-220. Tests for inclusion of substance in Schedule III.

Section 44-53-230. Schedule III.

Section 44-53-240. Tests for inclusion of substance in Schedule IV.

Section 44-53-250. Schedule IV.

Section 44-53-260. Tests for inclusion of substance in Schedule V.

Section 44-53-270. Schedule V.

Section 44-53-280. Promulgation of rules and regulations; requirement of professional license; expiration of registration; failure to renew registration; reinstatement; fees and penalties.

Section 44-53-290. Requirement of and authority granted by registration; individuals exempt from registration; registration for maintenance and detoxification treatment.

Section 44-53-300. Granting of registration.

Section 44-53-310. Grounds for denial, revocation, or suspension of registration; civil fine.

Section 44-53-320. Procedure for denial, revocation, or suspension of registration; administrative consent order.

Section 44-53-330. Copy of judgment sent to licensing board upon conviction.

Section 44-53-340. Records and inventories of registrants.

Section 44-53-350. Order forms for distribution of controlled substances.

Section 44-53-360. Prescriptions.

Section 44-53-361. Prescriptions for opioid antidotes.

Section 44-53-362. Controlled substance take-back events and mail-back programs; collectors.

Section 44-53-363. Prerequisites to issuing opioid analgesics to minors.

Section 44-53-365. Theft of controlled substance; penalty.

Section 44-53-370. Prohibited acts A; penalties.

Section 44-53-375. Possession, manufacture, and trafficking of methamphetamine and cocaine base and other controlled substances; penalties.

Section 44-53-376. Disposal of waste from production of methamphetamine; penalty; emergency or environmental response restitution; exemptions.

Section 44-53-378. Exposing child to methamphetamine.

Section 44-53-380. Prohibited acts B; penalties.

Section 44-53-390. Prohibited acts C; penalties.

Section 44-53-391. Unlawful to advertise for sale, manufacture, possess, sell or deliver, or to possess with intent to sell or deliver, paraphernalia.

Section 44-53-392. Weight of controlled substance.

Section 44-53-395. Prohibited acts; penalties.

Section 44-53-398. Sale of products containing ephedrine or pseudoephedrine; penalties; training of sales personnel.

Section 44-53-400. Penalties in article in addition to those under other laws.

Section 44-53-410. Prosecution in another jurisdiction shall be bar to prosecution.

Section 44-53-420. Attempt and conspiracy; attempt to possess; penalties.

Section 44-53-430. Appeals from orders of Department.

Section 44-53-440. Distribution to persons under eighteen.

Section 44-53-445. Distribution of controlled substance within proximity of school.

Section 44-53-450. Conditional discharge; eligibility for expungement.

Section 44-53-460. Reduced sentence for accommodation offenses.

Section 44-53-470. "Second or subsequent offense" defined; certain convictions considered prior offenses.

Section 44-53-475. Financial transactions, monetary instruments, or financial institutions involving property or proceeds of unlawful activities in narcotic drugs or controlled substances; penalties.

Section 44-53-480. Enforcement.

Section 44-53-485. Handling of seized controlled substances; use of photographs or videotapes of substances at trial; admissibility of evidence.

Section 44-53-490. Drug inspectors.

Section 44-53-500. Procedure for issuance and execution of administrative inspection warrants.

Section 44-53-520. Forfeitures.

Section 44-53-530. Forfeiture procedures; disposition of forfeited items; disposition of proceeds of sales.

Section 44-53-540. Burden of proof.

Section 44-53-550. Prosecutions prior to effective date of article.

Section 44-53-560. Repealed.

Section 44-53-570. Service of search warrants.

Section 44-53-577. Illegal acts involving persons under seventeen years of age; penalties; separate offense.

Section 44-53-582. Return of monies used to purchase controlled substances.

Section 44-53-586. Return of seized items to innocent owners; notice of hearing or rule to show cause; continuation of liens of innocent persons.

Section 44-53-590. Penalty for use of property in manner which makes it subject to forfeiture.

Section 44-53-610. Short title.

Section 44-53-620. Definitions.

Section 44-53-630. Establishment of therapeutic research program; regulations; limits as to patient eligibility.

Section 44-53-640. Patient Qualification Review Advisory Board; membership; compensation; duties.

Section 44-53-650. Director to obtain and distribute marijuana.

Section 44-53-660. Annual report.

Section 44-53-710. Exclusive control over methadone vested in Department of Health and Environmental Control.

Section 44-53-720. Restrictions on use of methadone.

Section 44-53-730. Restrictions on sale and distribution of methadone.

Section 44-53-740. Promulgation of rules and regulations.

Section 44-53-750. Autopsy on person dying while enrolled in program.

Section 44-53-760. Admission of minors to programs.

Section 44-53-810. Legislative findings.

Section 44-53-820. Establishment of DARE Fund; purpose.

Section 44-53-830. Board of directors; membership; terms.

Section 44-53-840. Board members to be reimbursed for expenses.

Section 44-53-850. Powers of board.

Section 44-53-860. Chairman; meetings; quorum.

Section 44-53-870. Director and staff; maximum administrative costs.

Section 44-53-880. Use of funds.

Section 44-53-890. Annual report.

Section 44-53-930. Retail sales shall be made only by registered pharmacists or assistant pharmacists; exception.

Section 44-53-950. Veterinarians and licensed durable medical equipment providers exception.

Section 44-53-960. Penalties.

Section 44-53-1110. Prohibition on aromatic hydrocarbons used as intoxicants.

Section 44-53-1120. Unlawful use or possession of aromatic hydrocarbons.

Section 44-53-1130. Penalties.

Section 44-53-1210. Definitions.

Section 44-53-1220. Sale of caustic or corrosive substance in misbranded parcel, package, or container prohibited.

Section 44-53-1230. Confiscation of misbranded caustic or corrosive substance parcels, packages, or containers.

Section 44-53-1240. Enforcement; approval of brands and labels.

Section 44-53-1250. Penalties.

Section 44-53-1310. Short title.

Section 44-53-1320. Definitions.

Section 44-53-1350. Exemptions.

Section 44-53-1360. Program for early diagnosis of cases of childhood lead poisoning; examinations; records.

Section 44-53-1370. Childhood lead poisoning prevention education program.

Section 44-53-1380. Notification of incidents of lead poisoning.

Section 44-53-1390. Investigation of lead poisoning case reports; right of entry.

Section 44-53-1400. Warrants for purpose of conducting investigation; oath or affirmation showing probable cause; contents of warrant.

Section 44-53-1430. Notice of identification of lead-based hazard; order that it be remediated; appeals.

Section 44-53-1440. Restriction on rental; existing occupants.

Section 44-53-1450. Regulations.

Section 44-53-1460. Legal actions not affected.

Section 44-53-1480. Penalties.

Section 44-53-1485. Civil penalties.

Section 44-53-1490. Private causes of action; action by municipality.

Section 44-53-1495. Funding contingency.

Section 44-53-1510. Definition of "anabolic steroid"; exceptions.

Section 44-53-1520. Unprofessional conduct to dispense under certain circumstances.

Section 44-53-1530. Possessing anabolic steroids without a prescription, or prescribing anabolic steroids, by nonpractitioner, pharmacist, or veterinarian unlawful; penalties.

Section 44-53-1550. What constitutes a prior offense.

Section 44-53-1610. Citation of article.

Section 44-53-1620. Purpose.

Section 44-53-1630. Definitions.

Section 44-53-1640. Authority to establish and maintain prescription monitoring program; electronic submission of information by dispensers; exemptions.

Section 44-53-1645. Requirement to review patient's prescription history.

Section 44-53-1650. Confidentiality; persons to whom data may be released.

Section 44-53-1655. Practitioner prescription report cards.

Section 44-53-1660. Contract for administration by other state agency or private vendor.

Section 44-53-1670. Promulgation of regulations.

Section 44-53-1680. Violations and penalties.

Section 44-53-1810. Definitions.

Section 44-53-1820. FDA approved clinical trials to treat patients who have certain forms of epilepsy with cannabidiol; principal investigators; subinvestigators.

Section 44-53-1830. Cannabidiol for use in clinical trials.

Section 44-53-1840. Immunity.

Section 44-53-1910. Definitions.

Section 44-53-1920. Limited immunity for a person who seeks medical assistance for another.

Section 44-53-1930. Limited immunity for overdose victim.

Section 44-53-1940. Decision to seek medical assistance a mitigating factor.

Section 44-53-1950. Limitation of immunity to allow prosecution for other crimes arising out of the drug or alcohol-related overdose.

Section 44-53-1960. Construction of article.

Section 44-53-1970. Civil and criminal immunity for law enforcement officers.